8,041 Shares in Smith & Nephew SNATS, Inc. $SNN Acquired by Pinnacle Wealth Planning Services Inc.

Key Points

• Pinnacle Wealth Planning Services Inc. has purchased 8,041 shares of Smith & Nephew SNATS, Inc. valued at approximately $228,000 during the first quarter.
• Analysts have recently upgraded Smith & Nephew SNATS from a "buy" rating to a "strong-buy", with a new target price set at $36.00.
• The company announced a $0.285 semi-annual dividend, resulting in a dividend yield of 2.10%, with the payout ratio currently at 26.39%.

Pinnacle Wealth Planning Services Inc. bought a new position in Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 8,041 shares of the medical equipment provider's stock, valued at approximately $228,000.

A number of other large investors have also recently bought and sold shares of SNN. Hexagon Capital Partners LLC lifted its holdings in Smith & Nephew SNATS by 63.3% in the first quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 406 shares during the last quarter. Richards Merrill & Peterson Inc. lifted its holdings in Smith & Nephew SNATS by 500.0% in the first quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider's stock worth $34,000 after acquiring an additional 1,000 shares during the last quarter. Bessemer Group Inc. increased its stake in shares of Smith & Nephew SNATS by 3,471.4% in the first quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock valued at $49,000 after purchasing an additional 1,701 shares during the period. Hara Capital LLC increased its stake in shares of Smith & Nephew SNATS by 391.4% in the fourth quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider's stock valued at $60,000 after purchasing an additional 1,957 shares during the period. Finally, Opal Wealth Advisors LLC acquired a new stake in shares of Smith & Nephew SNATS in the first quarter valued at approximately $73,000. Institutional investors own 25.64% of the company's stock.

Smith & Nephew SNATS Price Performance

Shares of NYSE SNN traded up $0.46 during mid-day trading on Wednesday, reaching $37.36. 538,338 shares of the company traded hands, compared to its average volume of 837,086. Smith & Nephew SNATS, Inc. has a fifty-two week low of $23.69 and a fifty-two week high of $37.65. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40. The firm has a market cap of $16.36 billion, a PE ratio of 17.30, a price-to-earnings-growth ratio of 1.03 and a beta of 0.71. The stock has a fifty day simple moving average of $33.27 and a 200-day simple moving average of $29.88.

Smith & Nephew SNATS Cuts Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 3rd will be paid a dividend of $0.285 per share. This represents a dividend yield of 210.0%. The ex-dividend date is Friday, October 3rd. Smith & Nephew SNATS's dividend payout ratio (DPR) is currently 41.20%.

Wall Street Analyst Weigh In

Several brokerages have commented on SNN. Wall Street Zen upgraded shares of Smith & Nephew SNATS from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Canaccord Genuity Group raised their price target on shares of Smith & Nephew SNATS from $28.00 to $36.00 and gave the company a "hold" rating in a research note on Monday, August 18th. Six analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $36.00.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.